High Content 2021
High Content 2021 concluded on October 6. Proceedings will remain available on LabRoots through October 6, 2022. Registration is required to view the proceedings.
Keynote speakers for High Content 2021:
Yinyin Yuan, Ph.D.
Team Leader, Computational Pathology and Integrative Genomics
The Institute of Cancer Research, London
Aydogan Ozcan, Ph.D.
Chancellor’s Professor and HHMI Professor, Samueli Electrical & Computational Engineering
University of California, Los Angeles
For the 8th year, the Society of Biomolecular Imaging and Informatics (SBI2) and SLAS co-hosted the HCS/HCA Data and Informatics Special Interest Group (SIG). This year, Society member Shannon Mumenthaler chaired the event:
High content imaging approaches to organs-on-chips: recent advancements and future prospects
Click here to view the virtual SIG event (SLAS sign in required)
2020 – 2021 Webinar Series
Our 2020 - 2021 Webinar Series has been archived.
Click here to view.
SBI2, as a 501(c)3 non-profit organization, holds a business meeting every year to review major activities, financial details and outlook for the coming year. The 2021 virtual meeting will take place in the fall. The date will be announced soon.
The meeting is open to the public and we certainly would be glad if you can join. For those of you who have interacted with SBI2 in the past, such as attending one of our annual meetings and have found your interactions with us beneficial and enjoyable, this meeting is a great opportunity to learn more about how to participate in the society. This includes learning about open positions at the leadership level or in more targeted roles such as education, data standards, conference planning and other roles.
We hope you can attend !
SBI2 statement on COVID-19
The SBI2 leadership has actively monitored the 2019 coronavirus (COVID-19) situation over the past year with the health and safety of our membership, students, exhibitors, partners, volunteers, and communities as the priority. We have considered information from many sources and manage our activities in a manner consistent with CDC guidelines intended to reduce transmission of COVID-19.